Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.
Saved in:
| Title: | Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation. |
|---|---|
| Authors: | Chin, Simone1,2 (AUTHOR), Con, Danny2,3 (AUTHOR), Hilley, Patrick2,3 (AUTHOR), Corte, Crispin1,4 (AUTHOR), Liu, Ken1,4 (AUTHOR), Testro, Adam2,5,6 (AUTHOR), De Cruz, Peter2,3 (AUTHOR) ppdecruz@gmail.com, Choy, Matthew C.2,3 (AUTHOR), Srinivasan, Ashish2,3,7 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Nov2025, Vol. 62 Issue 10, p1003-1011. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.70283 |
